Pro
Maria L. de Ceballos, PhD, Group Leader in the Department of Neural Plasticity at the Cajal Institute in Spain, et al., wrote in their Feb. 23, 2005 Journal of Neuroscience article titled "Prevention of Alzheimer's disease Pathology by Cannabinoids: Neuroprotection Mediated by Blockage of Microglial Activation":
“Our results indicate that cannabinoid receptors are important in the pathology of AD [Alzheimer’s disease] and that cannabinoids succeed in preventing the neurodegenerative process occurring in the disease.”
Feb. 23, 2005